Avonex, Injektionslösung in einer Fertigspritze

7680567350027 CH-56735 Injektionslösung
Avonex, Injektionslösung in einer Fertigspritze
Avonex, Injektionslösung in einer Fertigspritze
Avonex, Injektionslösung in einer Fertigspritze
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Packung(en)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
14/05/2024
Patient information leaflet
Français
14/05/2024
Patient information leaflet
Italien
14/05/2024
Summary of Product Characteristics
Allemand
14/05/2024
Summary of Product Characteristics
Français
14/05/2024
Summary of Product Characteristics
Italien
14/05/2024

Detailed composition

Substance Quantity Type Category
(N/A)
30.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
0.13 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 909.25
Specialties list
Yes
Generic
No
SL addition date: 01/09/2005

Authorization holder

Biogen Switzerland AG

6340 Baar

Authorization information

Swissmedic authorization number
56735
Drug name
Avonex, Injektionslösung in einer Fertigspritze
Galenic form
LSPA
ATC Code
L03AB07
Authorization status
Z
Dispensing category
B
First authorization
09/02/2005
Authorization expiration date
31/12/9999
IT Number
01.99.0.
Domain
Human medicine
Field of application
Multiple Sklerose

Package details

Description (FR)
AVONEX sol inj 4 ser pré 0.5 ml
Description (DE)
AVONEX Inj Lös 4 Fertspr 0.5 ml
Market launch
09/02/2005
Narcotic (BTM)
No